Max Salm

Max Salm is a data scientist specializing in molecular biology and oncology. He completed an interdisciplinary PhD at Imperial College London, focusing on immunotherapy, clinical genomics, and biomarker discovery. Max has numerous first author publications in high impact journals like Science and Nature Genetics, with over 3000 citations. His work clarifies the role of structural variation and genomic diversity in tumors. With over 10 years of programming experience in R, Max applies data mining, machine learning, and predictive modeling techniques in High Performance Computing environments, particularly with 'big data' like second generation sequencing data.

Max enjoys collaborating in highly interdisciplinary teams and creating innovative algorithmic solutions to advance personalized medicine. His specialties include genomics, bioinformatics, oncology, and medical genetics. Max obtained a BSc in Biology from the University of Bristol and a PhD in Medical Genetics from Imperial College London. His professional experience includes roles as a Team Leader of Bioinformatics Research and a Principal Bioinformatics Scientist at Achilles Therapeutics Limited, as well as positions at Thomson Reuters, Cancer Research UK, Barts and the London School of Medicine and Dentistry, and Wellcome Trust Sanger Institute.